(Q47134413)
Statements
1 reference
The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model (English)
1 reference
Katharine Victoria Jensen
Orsolya Cseh
Ahmed Aman
18 December 2017
1 reference
18 December 2017
1 reference